Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer
R L Souhami, R M Rudd, S G Spiro, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2001
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma
C W Mulatero, R T Penson, D Papamichael, et al.
British Journal of Diseases of the Chest
|
January 1, 1984
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing
P R Studdy, R M Rudd, A R Gellert, et al.
Thorax
|
July 1, 1985
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability
A R Gellert, J A Langford, R J Winter, et al.
Respiratory Medicine
|
May 1, 1989
Pleural mesothelioma resulting from exposure to amosite asbestos in a building
R C Stein, J Y Kitajewska, J B Kirkham, et al.
Lancet (London, England)
|
April 29, 1995
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?
P Wilkinson, D M Hansell, J Janssens, et al.
Respiratory Medicine
|
February 1, 1994
Respiratory muscle function in patients with asbestos-related pleural disease
N A Jarad, M P Carroll, C Laroche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2000
Phase II study of vinorelbine in patients with malignant pleural mesothelioma
J P Steele, J Shamash, M T Evans, et al.
European Journal of Respiratory Diseases
|
November 1, 1984
Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease
J A Wedzicha, F E Cotter, R M Rudd, et al.
British Medical Journal (Clinical Research Ed.)
|
February 12, 1983
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease
J A Wedzicha, R M Rudd, M C Apps, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phase II study of Edatrexate in stage III and IV non-small-cell lung cancer
R L Souhami, R M Rudd, S G Spiro, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 13, 2001
A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma
C W Mulatero, R T Penson, D Papamichael, et al.
British Journal of Diseases of the Chest
|
January 1, 1984
Bronchoalveolar lavage in the diagnosis of diffuse pulmonary shadowing
P R Studdy, R M Rudd, A R Gellert, et al.
Thorax
|
July 1, 1985
Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability
A R Gellert, J A Langford, R J Winter, et al.
Respiratory Medicine
|
May 1, 1989
Pleural mesothelioma resulting from exposure to amosite asbestos in a building
R C Stein, J Y Kitajewska, J B Kirkham, et al.
Lancet (London, England)
|
April 29, 1995
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?
P Wilkinson, D M Hansell, J Janssens, et al.
Respiratory Medicine
|
February 1, 1994
Respiratory muscle function in patients with asbestos-related pleural disease
N A Jarad, M P Carroll, C Laroche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2000
Phase II study of vinorelbine in patients with malignant pleural mesothelioma
J P Steele, J Shamash, M T Evans, et al.
European Journal of Respiratory Diseases
|
November 1, 1984
Erythrapheresis compared with placebo apheresis in patients with polycythaemia secondary to hypoxic lung disease
J A Wedzicha, F E Cotter, R M Rudd, et al.
British Medical Journal (Clinical Research Ed.)
|
February 12, 1983
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease
J A Wedzicha, R M Rudd, M C Apps, et al.
Page
of 10